Modulation of GITR for cancer immunotherapy
- 12 January 2012
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 24 (2) , 217-224
- https://doi.org/10.1016/j.coi.2011.12.011
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Science gone translational: the OX40 agonist storyImmunological Reviews, 2011
- The glucocorticoid-induced TNF receptor family-related protein (GITR) is critical to the development of acute pancreatitis in miceBritish Journal of Pharmacology, 2010
- Control of Immunity by the TNFR-Related Molecule OX40 (CD134)Annual Review of Immunology, 2010
- Glucocorticoid-Induced TNFR-Related (GITR) Protein and Its Ligand in Antitumor Immunity: Functional Role and Therapeutic ModulationClinical and Developmental Immunology, 2010
- OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosisThe Journal of Experimental Medicine, 2009
- OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejectionThe Journal of Experimental Medicine, 2008
- Glucocorticoid-induced Tumor Necrosis Factor Receptor Negatively Regulates Activation of Human Primary Natural Killer (NK) Cells by Blocking Proliferative Signals and Increasing NK Cell ApoptosisJournal of Biological Chemistry, 2008
- Structural basis for ligand-mediated mouse GITR activationProceedings of the National Academy of Sciences, 2008
- Evolution of GITRL immune function: Murine GITRL exhibits unique structural and biochemical properties within the TNF superfamilyProceedings of the National Academy of Sciences, 2008
- GITR modulates innate and adaptive mucosal immunity during the development of experimental colitis in miceGut, 2007